Along with hereditary myopathies, there are many exogenic (the same a not hereditary) muscle affections due to the pathology of endocrine gland's functioning. These forms of muscle pathology are called endocrine myopathies. In the cases of thyroid gland hyperfunction (the same a thyrotoxicosis), different regions of neuromuscular system may be involved in the pathological process. Thyrotoxic myopathy (TM) which is a subject of this investigation, occupies one of the first places between thyrotoxic (the same a thyrotoxicosis) neuromuscular affections. Meanwhile, for a long time in literature there was no clarity about the degree of muscle weakness and atrophy to diagnose TM in a patient. It's because of the fact that the majority of patients complain of increased fatigue and general weakness due to thyrotoxicosis. In present time TM diagnostics is very rare. TM is a phenocopy (the clinical similar) of many neuromuscular diseases. However in literature, the data about peculiarities of clinical picture of TM is almost completely absent, it isn't known about the frequency of affection of the isolated muscles or muscle groups, the topography of muscle weakness and successive involvement of isolated muscles in the pathological process during different stages of thyrotoxicosis and myopathy. The questions of differential diagnosis with similar neuromuscular disorders are described very poorly. In present article, we accent our attention at the clinical differentiation of the TM with other neuromuscular diseases, namely muscular dystrophy, myasthenia gravis, polymyositis, Addison's disease, proximal spinal muscular atrophy, steroid myopathy and neurosis. In our opinion, the early diagnosis of TM may help the diagnosis of thyrotoxicosis in patients who have no classical clinical signs of this disease, i.e. in patients with latent thyrotoxicosis.
Introduction
Side by side with hereditary types of myopathy, there is a special class of muscular affections that were influenced by the disturbances of endocrine glands.
Thyrotoxic (the same a thyrotoxicosis) myopathy (TM) is found oftener than the other thyroid neuromuscular disease (encephalomyelopathy (simultaneously affection of brain and spinal cord), polyneuropathy, exophthalmic ophthalmoplegia (In ophthalmic Graves' disease, the commonest of exophthalmic ophthalmoplegia-Bannister R. Brain and Bannister's Clinical Neurology, 7 Ed., Oxford 1992, p.53), hypokalemic paralysis, myasthenia syndrome, syndrome amyotrophic lateral sclerosis (syndrome ALS), cerebellar ataxia). In 1938, TM was picked out as an independent nosological type [1] (In 1938, Brain and Turnbull intheir classification of muscle affections by thyrotoxicosis described thyrotoxic myopathy acute and chronic forms). At present, TM is diagnosed very seldom, which is the result of the fact that doctors-practitioners do not often come across this clinical picture of the disease. There is an opinion as well as if the thyrotoxicosis weakness is always affected by common asthenia and not by the affection of the skeletal muscles. There are some objective reasons that make the diagnosis of TM difficult. They are: relatively light affection of separate muscles, absence of paralysis (there are rare exception); disguise of myopathy with the symptoms of the thyrotoxicosis and corresponding complaints of patients. As a rule, TM patients do not complain on muscular weakness and explain difficulties when moving with the help of some other reasons (leanness, overstrain, age, "lay by salt", etc.). What makes the diagnosis more difficult is the absence of muscle atrophy and muscles look "healthy" often.
All said is the reason of the fact that the research of neuromuscular system of patients having TM does not take place and myopathy is not diagnosed. Meanwhile if to arrange a special clinical research it can distinguish 61% -81.5%, if to use electromyography, 92.6% -100% of TM patients can be picked out [2] 
Material and Method
We studied the results of research of 263 TM patients, 47 men and 216 women (151 cases of our own investigations and 112 published in medical literature).
The clinical characteristic of TM patients and methods of research were described by us earlier [2] [7] . TM as well as the other endocrine muscle affections refers to the group of later myopathies. The age of the examined patients was from 16 to 70 years old (the average age 47.7 years old), the age of the patients described by some other authors was from 6 to 83 (the average age-50.3 years old). Some data say that both men and women suffer from this disease equally often [8] ; some researchers say that women suffer from this disease 2.3 -5.6 times oftener than men. The majority of TM patients have symptoms of the dis- A severe type of TM is managed to be diagnosed when there are well-known signs of thyrotoxicosis increasing of thyroid gland, exophthalmos and tachycardia). Real difficulties arise in cases when thyrotoxicosis develops latently and the patient did not have any goiter and exophthalmos. In this situation the appearance of muscular affections could be considered as a neuromuscular disease that is not connected with thyrotoxicosis. It is considerable difficult represent to diagnose a light degree of myopathy, especially at elderly people: the appearance of weakness and atrophy can be considered as age changes. There is opinion [6] [9] that if an elderly man has a progressive muscular weakness, which is difficult to explain, and atrophy againsta background of total leanness, than we can suppose that it is polymyositis may be of paraneoplastic nature.
According to the clinical data and morphological changes in muscles and electromyography as well TM is a phenocopy (the clinical similar) of some hereditary and unhereditary (not hereditary) neuromuscular diseases. It is very important to distinguish this exogenous myopathy from similar diseases as the treatment leads to almost a complete regress of TM; consequently timely diagnosis is vitally necessary. In cases when special treatment of TM is not done, the muscular weakness increases, the patient cannot move by himself (the same an independent). Very severe changes weakness of bulbar [10] [11], breathing and diaphragm muscles can be seen at some patients [12] . Some patients of death from TM are described.
Results and Discussion
A group of diseases with which it is necessary to differentiate TM is defined with the degree of its expressiveness. Severe types with the expressed atrophy of muscles it is necessary to distinguish from muscular dystrophies, paraneoplastic myopathy, proximal spinal muscular atrophy and diabetic proximal amyotrophy (atrophy proximal muscles); when we mention bulbar affections we should distinguish it from polymyositis, Addison's disease and steroid myopathy.
We can find out phenotypically similarity of TM with limb-girdle variants of muscular dystrophy [2] [3] [7] . However complaints of patients having muscular dystrophy of the muscle weakness and moving changes affected by it are leading ones here, there as in TM patients predominate of the "thyrotoxic complaints"
(However in patients with muscular dystrophy the complaints as a rule connected with muscle weakness and motor disturbances, but in TM patients predominate of the "thyrotoxic complaints" (the classical complaints which characteristic for thyrotoxicosis). We would like to add to this that the hereditary type of muscular dystrophy develops very slowly, for a period of some years, whereas myopathic (the weakness of definite muscles) signs at patients having TM arise In patients having muscular dystrophy feel weakness of muscles that comes after atrophy (excluding pseudohypertrophic muscles are exceptions). TM patients have "weak" muscles that keep very often normal volume and muscle being atrophied keeps muscular force in a considerable degree. Such disproportion between the degree of weakness and atrophy of muscles is a very important sign of TM. To our mind, the disappearance of subcutaneous fatty tissue created false impression of severe atrophy of the muscle. With this fact, it is connected with another important clinical sign. This is extraordinary skin folding in the field of the muscle that was affected, especially the triceps brachii and quadriceps femoris muscles. It was these muscles that keep the full strength but seems to be most atrophied. Patients suffering of muscular dystrophy do not have the phenomenon of considerate skin folding above the muscle that was affected been if there is no muscular venter at all. It is necessary to add that deep reflexes in patients with muscular dystrophy lessen very early and disappear were as they remain normal or increase at TM patients.
Some TM patients have weakness of proximal and distal muscles and simultaneously bulbar muscles are found to be affected [8] [10] [11] . In these cases it is necessary to differentiate TM not only with muscular dystrophy (oculopharengeal (oculopharyngeal) form) but as well with proximal spinal muscular Presence of fasciculations witnesses very convincingly against TM. Pyramidal tract affection in TM patients occurs very rarely [14] .
Great difficulties arise to differentiate of TM and idiopathic polymyositis [15] .
There is some clinical similarity between these two diseases: expressed general The clinical signs of muscular affections arising at steroid therapy may remain similar signs TM has. We observed some patients who had weakness and atrophy of pelvic girdle and hip muscles against the background of treatment by prednisolone in case of collagenous disease [2] . By the moment of development of muscle affections all these patients had features of Cushing syndrome. Rather often one could find dark red stripes on the abdomen and hips, painfulness of muscles while palpation. Muscular atrophy was more expressed than at TM patients. Simultaneously with the changes of pelvic girdle muscles one could expose considerable atrophy and weakness of muscles of lower arm and wrists.
Mixed changes (myogenic and neurogenic) were fixed at electromyograms. After abolishing to take hormones the regress of myopathy was marked.
The level of sugar in blood can be increased at thyrotoxic patients. The majority of patients having thyrotoxicosis disease have the signs neuroses-like state: effective emotional instability, tears-coming, fouling or trouble, fussiness, quick psychiatric fatiguability, depression and oppression of psychics and euphoria. In connection with this one of the mostly commonly-used mistakes in differentiating TM is the diagnosis of functional disorder of nervous system. There is common opinion that very often the patients with thyrotoxic disease complain of the weakness that is the consequence of the increased fatiguability and of exhaustion of psychiatric nature (i.e. asthenia). As a result of this, there are no investigations of the state of muscular function; possibility of affected skeletal muscles in the genesis of weakness is not taken into consideration. Meanwhile at the very early stage, TM can be diagnosed using different clinical criteria [2] In terms of the using treatment of patient suffering thyrotoxic disease with the appearance of myopathy, this treatment according to the data of medical literature and our experimental study is actually a pathogenic one and its effectiveness is defined by this [2] [3] [7] [18] [19] [20] [21] .
Taking into consideration the theoretical preconditions about the participation of cyclic nucleotides and Ca ++ in the pathogenesis of muscular weakness at TM patients [20] , we should think it necessary to use medicines that increase the level of cyclic AMP in skeletal muscles (allopurinol, aminophylline, trental). For making the calcium exchange normal, it is necessary to prescribe natrium oxalate increases the ability of sarcoplasmic reticulum to accumulation calcium iones; antagonists of calcium iones (verapamil, nifedipine). After disappearance of the signs of thyrotoxicosis, it is worthwhile to repeat the periods of pathogenic treatment of myopathy (alfa-tocopherol, vitamin B-12, nerobol).
